Oral Rivaroxaban As Prevention For Symptomatic Venous Thromboembolism

In this study data from three studies comparing the new oral anticoagulant rivaroxaban against enoxaparin injected subcutaneously was assessed and conclusions drawn about effectiveness of both types of treatment. Rivaroxaban was started six to eight hours after surgery, whereas enoxaparin was injected the previous evening and then at six to eight hours following wound closure.

More: continued here

Filed under: Blood on June 5th, 2009